These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10935490)

  • 21. Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosine kinase 3 (FLT3).
    Murata K; Kumagai H; Kawashima T; Tamitsu K; Irie M; Nakajima H; Suzu S; Shibuya M; Kamihira S; Nosaka T; Asano S; Kitamura T
    J Biol Chem; 2003 Aug; 278(35):32892-8. PubMed ID: 12815052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs.
    Chaturvedi P; Sharma S; Reddy EP
    Mol Cell Biol; 1997 Jun; 17(6):3295-304. PubMed ID: 9154828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSPA1A is an important regulator of the stability and function of ZNF198 and its oncogenic derivative, ZNF198-FGFR1.
    Kasyapa CS; Kunapuli P; Cowell JK
    J Cell Biochem; 2007 Dec; 102(5):1308-17. PubMed ID: 17471537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
    Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ
    Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
    Haq R; Halupa A; Beattie BK; Mason JM; Zanke BW; Barber DL
    J Biol Chem; 2002 May; 277(19):17359-66. PubMed ID: 11875080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
    Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
    Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling.
    Ho JM; Beattie BK; Squire JA; Frank DA; Barber DL
    Blood; 1999 Jun; 93(12):4354-64. PubMed ID: 10361134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
    Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
    Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.
    Ollendorff V; Guasch G; Isnardon D; Galindo R; Birnbaum D; Pébusque MJ
    J Biol Chem; 1999 Sep; 274(38):26922-30. PubMed ID: 10480903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
    Chase A; Grand FH; Cross NC
    Blood; 2007 Nov; 110(10):3729-34. PubMed ID: 17698633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
    Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
    Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of four new translocations involving FGFR1 in myeloid disorders.
    Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
    Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase.
    Kouhara H; Kurebayashi S; Hashimoto K; Kasayama S; Koga M; Kishimoto T; Sato B
    Oncogene; 1995 Jun; 10(12):2315-22. PubMed ID: 7784079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.
    Demoulin JB; Uyttenhove C; Van Roost E; DeLestré B; Donckers D; Van Snick J; Renauld JC
    Mol Cell Biol; 1996 Sep; 16(9):4710-6. PubMed ID: 8756628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
    Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
    Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation.
    Kovalenko D; Yang X; Nadeau RJ; Harkins LK; Friesel R
    J Biol Chem; 2003 Apr; 278(16):14087-91. PubMed ID: 12604616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
    Dell'Era P; Mohammadi M; Presta M
    Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.